A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects-Reference-Cited by-同舟云学术

A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects

Published:2001-04 Issue:23-24 Volume:19 Page:3033-3042
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lambert John S,Keefer Michael,Mulligan Mark J,Schwartz David,Mestecky Jiri,Weinhold Kent,Smith Carol,Hsieh Ray,Moldoveanu Zina,Fast Patricia,Forrest Bruce,Koff Wayne

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. The emergence of simian/human immunodeficiency viruses;Myers;AIDS Res. Hum. Retrovir.,1992

2. Pathogenesis of human immunodeficiency disease virus infection;Levy;Microbiol. Rev.,1993

3. Development and testing of AIDS vaccines;Koff;Science,1988

4. HIV vaccines;Frey;Infect. Dis. Clin. North Am.,1999

5. New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview. CR Acad Sci Paris. Sciences de la vie;Girard;Life Sci.,1999

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides for Vaccine Development;ACS Applied Bio Materials;2022-02-23

2. Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission;Current Immunology Reviews;2019-04-12

3. Recent progress in adjuvant discovery for peptide-based subunit vaccines;Human Vaccines & Immunotherapeutics;2013-12-03

4. Delivery of immunogens to mucosal immune system using an oral inactivated cholera vaccine;Human Vaccines & Immunotherapeutics;2013-03-06

5. Injectable PLGA Systems for Delivery of Vaccine Antigens;Long Acting Injections and Implants;2011-09-13